- Home
- XFOR vs AVBH Comparison
XFOR vs AVBH Comparison
Compare XFOR & AVBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | AVBH |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.3M | 284.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | XFOR | AVBH |
|---|---|---|
| Price | $3.93 | $27.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $28.50 | ★ $29.17 |
| AVG Volume (30 Days) | ★ 603.4K | 37.0K |
| Earning Date | 11-05-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,979,000.00 | $22,129,000.00 |
| Revenue This Year | $1,276.65 | $19.35 |
| Revenue Next Year | N/A | $17.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2925.74 | N/A |
| 52 Week Low | $1.35 | $19.75 |
| 52 Week High | $26.83 | $27.70 |
Technical Indicators
Market Signals| Indicator | XFOR | AVBH |
|---|---|---|
| Relative Strength Index (RSI) | 55.65 | N/A |
| Support Level | $3.53 | N/A |
| Resistance Level | $4.07 | N/A |
| Average True Range (ATR) | 0.28 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 80.88 | 0.00 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About AVBH Avidbank Holdings Inc. Common stock
Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.